NCT06715553Active, not recruiting
Interventional Programs' Impact on Patients' Quality of Life and Functioning
The Effect of Interventional Programs on Quality of Life and Functioning Among Patients With Schizophrenia
Source: ClinicalTrials.gov · Last updated 10 Mar 2025
Brief summary (registry, in English)
The objective of the study is to investigate the effect of interventional program in improving the quality of life for individuals with chronic schizophrenia The design of the study will be an interventional study - Randomized Control Trial - taking place in the Psychiatric hospital of the Cross Lebanon. Six types of intervention will be done on the patients such as ping-pong, sport exercise, psychoeducation program, nutrition, art therapy and bibliotherapy. A 100 patients adhering to the inclusion and exclusion criteria will be randomized into two groups (50 patients in the intervention group and 50 patients in the control group) - Simple Randomization. A Baseline and follow-up assessments will take place at the beginning of the study and after three months through using Arabic Validated Scales. The scales that be used are the following Positive and negative symptoms scale (PANSS), to determine severity of symptoms in patients. WHO quality of life questionnaire WHOQOL- BREF Arabic version: physical, psychological, social and environmental and EQ-5D scale, to determine quality of life of patients. MOCA scale to determine cognitive function, Rosenberg self-esteem questionnaire, Social functioning questionnaire QFS and Birchwood Insight Scale.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 86 (actual)
- First submitted
- 13 Nov 2024
- Start date
- 9 Aug 2024
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Psychiatric Hospital of the Cross
- Diseases
- Schizophrenia
- NCT number
- NCT06715553
What you commit to
- Study type: Interventional
- Participants enrolled: 86
- From 9 Aug 2024 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment
Other
- Active substance use
- Intellectual disability
Who the study is looking for
- Individuals diagnosed with chronic schizophrenia according to DSM-V criteria
- Aged 18-65.
- Physically capable of participating in physical
- Clinically stable
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psychiatric Hospital of the Cross Coordinator of this site? Confirm its status | Beirut | Lebanon | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.